The MyTreat Project consists of three partners from university, hospital and industry.

Diabetes Technology Research of the ARTORG Center for Biomedical Engineering Research

The Diabetes Technology Research (DTR) group of the ARTORG Center is an international, multidisciplinary research group of about 15 people: post-doctoral researchers, PhD and MSc students and researchers from engineering and computer science. The diversity of our researchers enables DTR to approach diabetes from different perspectives. The group’s current research activities include i) adaptive data-driven, modelling and control of physiological systems, and ii) computer vision and artificial intelligence methods for diagnosis, treatment optimization and disease self-management. Group members have co-/ authored more than 150 articles in peer-reviewed papers in diabetes, diabetes technology and biomedical engineering. The research activities are funded by national (SNF, Inselspital, Schweizerische Diabetes Stiftung) and European funds, as well as by industry.

More details: http://www.artorg.unibe.ch/research/diabetes_technology/index_eng.html

Debiotech S.A.

Debiotech develops innovative medical devices based on micro- and nano-technology, microelectronics and new materials. More precisely, Debiotech concentrates on implantable and non-implantable devices for drug delivery and diagnostics. Debiotech’s core competence lies in the identification of breakthrough technologies and the development of new devices in this area. These devices are then licensed to major international pharmaceutical and medical device companies.

More details: www.debiotech.com

Division of Diabetes, Endocrinology, Nutritional Medicine & Metabolism (UDEM) of the Bern University Hospital “Inselspital”

The Division of Diabetes, Endocrinology, Nutritional Medicine & Metabolism (UDEM) is part of the University Hospital Bern (Inselspital), the largest Hospital in Switzerland. UDEM covers the entire spectrum of endocrine diseases with over 20’000 consultations per year, and has a specific focus on type 1 diabetes. The UDEM has a strong background and long-lasting clinical and research expertise in diabetes management and diabetes technology. In particular, the involved clinicians and researchers have been and are actively involved in a number of research projects funded by the SNF, other public and private foundations, and by the European Union related to diabetes mellitus. The UDEM research team has specific expertise in studies on CSII and CGM, and is particularly interested in diabetes-associated metabolism where novel clamp methods have been developed by this group.

More details: http://www.endokrinologie.insel.ch/